# Cancer Molecular Therapeutics

> **NIH NIH P30** · SANFORD BURNHAM PREBYS MEDICAL DISCOVERY INSTITUTE · 2024 · $80,566

## Abstract

The overall goals of the Cancer Molecular Therapeutics (CMT) Program (formerly Aging, Cancer and Immuno-oncology (ACI)) are to engage active collaborations among members of the program to enable new research initiatives and grant programs that will define how the interplay among cancer cells, immune cells, stromal components, and vasculature regulates the growth and metastasis of solid and hematologic malignancies, and to use this knowledge to discover new, more effective cancer treatments.

## Key facts

- **NIH application ID:** 11092506
- **Project number:** 5P30CA030199-43
- **Recipient organization:** SANFORD BURNHAM PREBYS MEDICAL DISCOVERY INSTITUTE
- **Principal Investigator:** Michael Jackson
- **Activity code:** P30 (R01, R21, SBIR, etc.)
- **Funding institute:** NIH
- **Fiscal year:** 2024
- **Award amount:** $80,566
- **Award type:** 5
- **Project period:** 2024-05-01 → 2025-04-30

## Primary source

NIH RePORTER: https://reporter.nih.gov/project-details/11092506

## Citation

> US National Institutes of Health, RePORTER application 11092506, Cancer Molecular Therapeutics (5P30CA030199-43). Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/grant/nih/11092506. Licensed CC0.

---

*[NIH grants dataset](/datasets/nih-grants) · CC0 1.0*